Immunocompetent αβ T cells must be reactive to foreign pathogens but tolerant of self ligands. Those critical features of T cell immunity are imposed by selection events in the thymus that determine the developmental fate of each individual T cell depending on the specificity of its T cell antigen receptor (TCR). Differentiation in the thymus proceeds in an ordered sequence characterized by expression of the coreceptors CD4 and CD8 in which the earliest cells are CD4 − CD8 − (double-negative (DN)) thymocytes that differentiate into CD4 + CD8 + (double-positive (DP)) thymocytes that then terminally differentiate into CD4 + or CD8 + (single-positive (SP)) T cells 1,2 . Thymocytes at the DP stage of differentiation are the first cells to express endogenous αβ TCR complexes and are the cells subjected to TCR-specific thymic selection. DP thymocytes are intrinsically short-lived cells whose continued survival requires signaling via the TCR by self ligands in the thymic cortex. TCR signaling rescues DP thymocytes from death by neglect and induces either positive or negative selection 1,2 . Positive selection is induced by low-affinity ligands and results in the differentiation of signaled DP thymocytes into conventional CD4 + SP (SP4) T cells or CD8 + SP (SP8) T cells with helper function or cytotoxic function, respectively, whereas negative selection is induced by high-affinity ligands that prevent DP thymoctyes that have received TCR signaling from continuing their differentiation into conventional SP T cells 3, 4 . Thus, the thymus imposes central tolerance by generating mature SP4 and SP8 T cells that express TCRs without substantial autoreactive potential.
A r t i c l e s
Immunocompetent αβ T cells must be reactive to foreign pathogens but tolerant of self ligands. Those critical features of T cell immunity are imposed by selection events in the thymus that determine the developmental fate of each individual T cell depending on the specificity of its T cell antigen receptor (TCR). Differentiation in the thymus proceeds in an ordered sequence characterized by expression of the coreceptors CD4 and CD8 in which the earliest cells are CD4 − CD8 − (double-negative (DN)) thymocytes that differentiate into CD4 + CD8 + (double-positive (DP)) thymocytes that then terminally differentiate into CD4 + or CD8 + (single-positive (SP)) T cells 1, 2 . Thymocytes at the DP stage of differentiation are the first cells to express endogenous αβ TCR complexes and are the cells subjected to TCR-specific thymic selection. DP thymocytes are intrinsically short-lived cells whose continued survival requires signaling via the TCR by self ligands in the thymic cortex. TCR signaling rescues DP thymocytes from death by neglect and induces either positive or negative selection 1, 2 . Positive selection is induced by low-affinity ligands and results in the differentiation of signaled DP thymocytes into conventional CD4 + SP (SP4) T cells or CD8 + SP (SP8) T cells with helper function or cytotoxic function, respectively, whereas negative selection is induced by high-affinity ligands that prevent DP thymoctyes that have received TCR signaling from continuing their differentiation into conventional SP T cells 3, 4 . Thus, the thymus imposes central tolerance by generating mature SP4 and SP8 T cells that express TCRs without substantial autoreactive potential.
The most definitive way of preventing autoreactive TCRs from appearing on mature SP T cells is the clonal deletion of DP thymocytes that bear autoreactive TCRs during negative selection in the thymus 5 .
However, strong TCR signaling of DP thymocytes does not necessarily result in thymocyte death. Indeed, a few DP thymocytes are strongly signaled by agonist ligands to differentiate into specialized SP4 T cell subpopulations with regulatory or natural killer functions 6, 7 , with such specialized differentiation referred to as 'agonist selection' 8 . In a similar vein, developing DP thymocytes do not undergo clonal deletion when they receive strong signaling by agonist ligands in the thymic cortex 9 . Consequently, strong TCR stimulation of DP thymocytes during negative selection seems to be insufficient by itself to induce clonal deletion. However, it is not known what, if any, additional in vivo signals are needed during negative selection to induce thymocytes to undergo clonal deletion.
A potentially useful insight may have been provided by longstanding in vitro studies showing that costimulation by CD28 is needed to induce the death of thymocytes that have received strong TCR signaling [10] [11] [12] [13] . Indeed in vitro costimulation by CD28 blocks upregulation of the antiapoptotic protein Bcl-2 by the TCR 14 , and transgenic overexpression of Bcl-2 rescues costimulated thymocytes from death induced by TCR signaling in vitro 12, 14 . Although it has been observed only in vitro, a requirement for CD28 costimulation in thymocyte death that results from TCR signaling is potentially consistent with observations that clonal deletion is mediated by thymic dendritic cells and medullary thymic epithelial cells but not by cortical thymic epithelial cells that differ in their expression of the CD28-costimulatory ligands CD80 and CD86 (refs. 9,15-17) . However, those in vitro results have been directly contradicted by multiple in vivo studies that investigated a role for CD28 costimulation in clonal deletion. Those studies have shown 5 7 0 VOLUME 13 NUMBER 6 JUNE 2012 nature immunology A r t i c l e s that autoreactive thymocytes are prevented from differentiating into either SP4 or SP8 T cells and that central tolerance is achieved regardless of the presence or absence of in vivo CD28 costimulation [18] [19] [20] [21] [22] .
Nonetheless, we undertook this study to determine if in vivo costimulation by CD28 during negative selection is important for either clonal deletion or central tolerance. Unlike the previously published in vivo studies [18] [19] [20] [21] [22] , we distinguished between negative selection and clonal deletion by considering the possibility that DP thymocytes that have received strong signaling and that bear autoreactive TCRs might survive negative selection even though they do not differentiate into conventional SP4 or SP8 T cells. In fact, we found that in vivo costimulation by CD28 during negative selection was required for autoreactive thymocytes to undergo clonal deletion but that neither costimulation by CD28 nor clonal deletion was critical for central tolerance. We also found that tolerance was induced during negative selection even in the absence of CD28-mediated clonal deletion because strong TCR signaling diverted DP thymocytes from differentiating into conventional SP T cells bearing autoreactive TCRs and directed their differentiation into TCRαβ + DN thymocytes, a process we refer to as 'developmental diversion' . Although developmentally diverted thymocytes expressed autoreactive TCRs, they were coreceptor negative and functionally anergic, which diminished their autoreactive potential. Moreover, when developmentally diverted TCRαβ + DN thymocytes left the thymus, they 'preferentially' migrated to the intestine, where they received signals to express homodimers of the coreceptor CD8α (CD8αα) and were sequestered in the gut as CD8αα + intraepithelial lymphocytes (IELs). Thus, we have identified CD28 as being critical for inducing autoreactive thymocytes to undergo clonal deletion during in vivo negative selection and have additionally identified CD8αα + IELs as the fate of autoreactive thymocytes that avoid clonal deletion during negative selection.
RESULTS

Clonal deletion versus rescue of autoreactive thymocytes
We began our assessment of intrathymic costimulation during negative selection by comparing thymocyte populations from wild-type mice and costimulation-deficient mice that lack either the costimulatory receptor CD28 (Cd28 −/− mice) or its two costimulatory ligands CD80 (B7-1) and CD86 (B7-2; called 'B7-deficient' mice here). In our analysis, we specifically looked for a thymocyte subpopulation that was present in costimulation-deficient (Cd28 −/− or B7-deficient) mice but was absent from wild-type mice. Costimulation-deficient mice on two different genetic backgrounds (C57BL/6 and BALB/c) had only modestly altered thymocyte numbers and a slightly greater frequency of DN cells relative to those of wild-type mice (Fig. 1a, top) . However, costimulation-deficient mice showed substantial enrichment for a specific subset of DN thymocytes that were TCRαβ + (Fig. 1a, bottom) . Unlike DN thymocytes from wild-type mice, which included few TCRαβ + cells that were mostly natural killer T cells, as determined by staining with tetramers of the antigen-presenting molecule CD1d, DN thymocytes from costimulation-deficient mice included a high frequency of TCRαβ + cells that were not natural killer T cells (Fig. 1b,c) .
If impaired clonal deletion in costimulation-deficient mice were the basis for greater abundance of TCRαβ + DN thymocytes, then impairing clonal deletion in costimulation-sufficient mice should also result in more TCRαβ + DN thymocytes. To test this prediction, we attempted to impair clonal deletion in wild-type mice through the use of transgenes encoding the antiapoptotic proteins Mcl-1 and Bcl-2 ( Fig. 2a) . Mcl-1-transgenic mice and Bcl-2-transgenic mice had substantially more TCRαβ + DN thymocytes than did wild-type mice, and these thymocytes were CD5 hi (Fig. 2a,b) , consistent with their having received strong signaling in vivo. Thus, thymocyte expression of transgenes encoding prosurvival molecules in wild-type mice had the same effect as costimulation deficiency-that is, more TCRαβ + DN thymocytes-which suggested that the TCRαβ + DN thymocyte subset contained cells that would otherwise have been clonally deleted.
To directly test the possibility that the TCRαβ + DN subset was enriched for thymocytes bearing autoreactive TCRs, we examined mice expressing endogenous superantigens. BALB/c mice express the proviral proteins Mtv-6, Mtv-8 and Mtv-9, which specifically engage TCRs containing β-chain variable region 3 (V β 3), V β 5, V β 11 a b
WT Cd28 npg and V β 12, so BALB/c thymocytes expressing those TCRs undergo clonal deletion 23 . Indicative of TCRβ-specific clonal deletion in wildtype BALB/c mice, all TCRαβ + thymocyte subsets (SP4, SP8 and DN) had considerably fewer thymocytes bearing the superantigen-reactive V β 3 + , V β 5 + and V β 11 + TCRs than did preselection DP thymocytes, whereas they had compensatorily more thymocytes bearing unreactive V β 8 + TCRs ( Fig. 3a and Supplementary Fig. 1a) . In contrast to wild-type BALB/c thymocytes, costimulation-deficient BALB/c thymocyte populations bearing Mtv-8-and Mtv-9-reactive TCRs (V β 5 + and V β 11 + ) had a uniquely greater frequency and number of TCRαβ + DN thymocytes but not SP4 or SP8 thymocytes (Fig. 3a) . Thus, thymocytes bearing Mtv-8-and Mtv-9-reactive V β 5 + and V β 11 + TCRs were not deleted in costimulation-deficient BALB/c mice but instead appeared as TCRαβ + DN thymocytes. We additionally analyzed Mtv-6 reactive TCRs but were initially confused by a discrepancy in thymocytes from Cd28 −/− mice and those from B7-deficient mice (Supplementary Fig. 1 ). SP4 and SP8 thymocytes of Cd28 −/− BALB/c mice were depleted of Mtv-6 reactive V β 3 + TCRs (Supplementary Fig. 1a) , as noted for other superantigenreactive TCRs (Fig. 3a) , but SP4 and SP8 thymocytes in B7-deficient BALB/c mice were not depleted of these TCRs (Supplementary Fig. 1a) , as reported before 24 . Our attempts to understand the basis for this discrepancy led us to discover that the gene encoding Mtv-6 was absent from B7-deficient BALB/c mice (Supplementary Fig. 1b) . This turned out to be due to the fact that this gene is on the same chromosomal segment as the genes encoding CD80 and CD86, which in B7-deficient mice was derived from embryonic stem cells of 129 origin that lacked the gene encoding Mtv-6. Consequently, B7-deficient mice did not have the gene encoding Mtv-6 in their genome, which explained the presence of thymocytes bearing the V β 3 + TCR in all B7-deficient BALB/c thymocyte subsets, including SP4 and SP8 cells.
Having resolved the discrepancy noted above, we then sought to determine if transgenes encoding Mcl-1 and Bcl-2 would prevent the deletion of superantigen-reactive thymocytes in costimulationsufficient wild-type mice. Both the Mcl-1 transgene and the Bcl-2 transgene did in fact prevent clonal deletion of thymocytes in wildtype mice, as the frequency and number of superantigen-reactive TCRs were greater among TCRαβ + DN thymocytes in Mcl-1-transgenic mice and Bcl-2-transgenic mice than in nontransgenic wild-type mice, with the Bcl-2 transgene having a greater effect than the Mcl-1 transgene (Fig. 3b) . On the basis of these results, we concluded that TCR signaling by high-affinity intrathymic ligands was sufficient to prevent autoreactive thymocytes from becoming SP thymocytes a b 
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A r t i c l e s but was not sufficient to induce clonal deletion, which additionally required intrathymic costimulation. In addition, we concluded that transgenes encoding the prosurvival molecules Mcl-1 and Bcl-2 prevented clonal deletion and that thymocytes rescued from clonal deletion appeared in the thymus as TCRαβ + DN thymocytes.
Derivation and selection of TCRab + DN thymocytes All TCRαβ + thymocytes are originally derived from TCR − DN precursor thymocytes that received signals from the pre-TCR to differentiate into DP thymocytes, and it is in DP thymocytes that endogenously encoded TCRαβ surface complexes are first expressed. Consequently, because TCRαβ + DN thymocytes bear endogenously encoded TCRαβ surface complexes, it is likely that they are the progeny of DP thymocytes. To determine if TCRαβ + DN thymocytes are indeed derived from DP thymocytes, we examined the methylation status of their Cd8b1 locus because it remains methylated until it is permanently demethylated when thymocytes first express CD8 to become DP cells 25 . In thymocyte populations from Bcl-2-transgenic mice that were enriched for TCRαβ + DN thymocytes, the Cd8b1 promoter was methylated in TCR − DN precursor thymocytes but was demethylated in DP thymocytes and in their post-selection SP4 and SP8 progeny ( Fig. 4a and Supplementary Fig. 2 ). The Cd8b1 promoter was also demethylated in TCRαβ + DN thymocytes ( Fig. 4a and Supplementary  Fig. 2 ), which showed that TCRαβ + DN thymocytes were the progeny of coreceptor-positive (DP) thymocytes.
Next we determined whether the generation of TCRαβ + DN thymocytes, like that of post-selection SP4 and SP8 thymocytes, required TCR-mediated thymic selection signals. Because TCR signaling in DP thymocytes is strictly dependent on the tyrosine kinase Zap70 (ref. 26) , we assessed the effect of Zap70 deficiency on the appearance of TCRαβ + DN thymocytes (Fig. 4b) . B7-deficient mice also deficient in Zap70 were devoid of TCRαβ + DN thymocytes (Fig. 4b) , which showed that the generation of TCRαβ + DN thymocytes was strictly dependent on signals transduced by Zap70. We further determined whether the generation of TCRαβ + DN thymocytes required intrathymic expression of major histocompatibility complexes (MHCs) because TCR-mediated thymic selection is MHC specific. Cd28 −/− mice that were additionally deficient in MHC (Cd28 −/− B2m −/− H2-Ab1 −/− ) were essentially devoid of TCRαβ + DN thymocytes (Fig. 4b) . These results showed that expression of both MHC and Zap70 was required for the in vivo generation of TCRαβ + DN thymocytes. We concluded that TCRαβ + DN thymocytes were the progeny of DP thymocytes and that the differentiation of DP thymocytes into a b Superantigen-reactive TCRs were present on intermediate thymocytes in both wild-type and costimulation-deficient BALB/c mice at frequencies that were essentially equal to those of preselection DP thymocytes (Fig. 5a) . In fact, superantigen-reactive TCRs were present at a much greater frequency among intermediate thymocytes that had received TCR signaling than among SP4 or SP8 post-selection thymocytes (Fig. 5a) , which indicated that DP thymocytes that had received strong signaling differentiated into intermediate thymocytes before undergoing clonal deletion or developmental diversion (Fig. 5a) . That is, in wild-type BALB/c mice, superantigen-reactive TCRs were present in intermediate thymocytes, but all post-selection populations lacked such TCRs (Fig. 5a) , which indicated that autoreactive thymocytes did not survive beyond the intermediate stage of differentiation. In costimulation-deficient BALB/c mice, superantigen-reactive TCRs were present in both intermediate and TCRαβ + DN thymocytes, but SP4 and SP8 post-selection thymocytes lacked such TCRs (Fig. 5a) 27 . In fact, surface expression of CD28 was upregulated during the differentiation of DP cells into intermediate and TCRαβ + DN thymocytes in B7-deficient mice, whereas it was downregulated on cells from B7-sufficent mice (Fig. 5b and Supplementary Fig. 3) , which showed that both intermediate thymocytes and TCRαβ + DN thymocytes in B7-sufficient mice (which survived because of transgenic overexpression of Bcl-2) were in contact with B7-expressing cells in the thymus and received strong costimulation in vivo.
We concluded that CD4 + CD8 lo intermediate thymocytes were located in an area of the thymus where they were able to contact B7 costimulatory ligands. Furthermore, the intermediate stage of differentiation was a point in thymocyte development during which clonal deletion and developmental diversion both occurred. Because the intermediate stage of differentiation is also the point in thymocyte development at which CD4-CD8 lineage choice occurs, we suggest that it was in intermediate thymocytes that different TCR signals were 'translated' into different lineage fates, depending on the intensity and duration of TCR signaling as well as the presence or absence of costimulation ( Supplementary Fig. 4) .
Characterization of developmentally diverted thymocytes
Next we analyzed the phenotype of developmentally diverted TCRαβ + DN thymocytes. This showed that during the differentiation of DP cells into developmentally diverted TCRαβ + DN thymocytes, a variety of molecules were upregulated (TCRβ, PD-1, CD5, CD69, CD122, Bcl-2 and α 4 β 7 ), whereas other molecules were either unchanged or Supplementary Fig. 5a,b) . The expression pattern of these surface molecules provided some potentially useful insights into the generation and fate of TCRαβ + DN thymocytes.
First, the upregulation of TCRβ, the activation markers CD5 and CD69 suggested that TCRαβ + DN thymocytes had received TCR signaling, and their high expression of the attenuator of TCR signaling PD-1 indicated that those in vivo TCR signals had been strong and persistent, as would be expected of autoreactive TCRs ( Supplementary  Fig. 5a ). Because surface PD-1 molecules dampen TCR signal transduction 28 , we then assessed the in vitro reactivity of TCRαβ + DN thymocytes. We determined that developmentally diverted TCRαβ + DN thymocytes were anergic cells on the basis of the following three findings: their TCRs did not induce calcium mobilization (Fig. 5c and Supplementary Fig. 6a ), they were unable to produce their own interleukin 2 (IL-2; Supplementary Fig. 6b ) and they required the addition of exogenous IL-2 to proliferate in response to stimulation with antibody to TCR (anti-TCR) and anti-CD28 (Fig. 5d) . We then considered whether PD-1 expression was required for developmental diversion. However, germline deletion of the gene encoding PD-1 did not affect the generation of developmentally diverted TCRαβ + DN thymocytes in B7-deficient mice (Supplementary Fig. 6c ). In addition, little or no surface expression of CD127 (IL-7 receptor α-chain) indicated that developmentally diverted TCRαβ + DN thymocytes were probably not dependent on IL-7 for their in vivo survival (Supplementary Fig. 5a ), unlike mature SP thymocytes and T cells. Indeed, despite their almost complete lack of CD127 expression, developmentally diverted TCRαβ + DN thymocytes had high expression of Bcl-2 and were not apoptotic in vivo (as shown by their lack of staining with annexin V or active caspase-3; Supplementary Fig. 5b ), possibly because they expressed CD122 (IL-2 receptor β-chain) and CD132 (common γ-chain), which conferred the potential to respond in vivo to IL-2 and IL-15 ( Supplementary Fig. 5a ). Moreover, developmentally diverted TCRαβ + DN thymocytes expressed the integrin α 4 β 7 (Supplementary Fig. 5a ), which indicated that they could potentially leave the thymus and migrate to the intestine. 
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into host mice deficient in recombination-activating gene 2 (Fig. 6a) . At 5 weeks after transfer, most developmentally diverted TCRαβ + DN thymocytes had homed to the small intestine and differentiated into TCRαβ + CD8αα + IELs, whereas SP8 T cells remained mainly TCRαβ + CD8αβ + T cells regardless of their homing destination (Fig. 6a) . Because IL-15 is present in the gut and because TCRαβ + DN thymocytes are potentially responsive to IL-15 because of their expression of CD122 and CD132, we wondered if IL-15 might contribute to the differentiation of TCRαβ + DN thymocytes into TCRαβ + CD8αα + cells. To assess this, we stimulated developmentally diverted TCRαβ + DN thymocytes in vitro with anti-TCRβ and IL-15 (Fig. 6b) . Indeed, by day 4 of culture, most TCRαβ + DN thymocytes that received such signaling had differentiated into TCRαβ + CD8αα + cells (Fig. 6b) . The results presented above showed that developmentally diverted TCRαβ + DN thymocytes had the potential to become TCRαβ + CD8αα + IELs, and they resembled results obtained with wild-type TCRαβ + DN thymocytes 29 , but we did not know if developmentally diverted TCRαβ + DN thymocytes actually differentiated into TCRαβ + CD8αα + IELs in vivo. To assess this, we took advantage of the finding that TCRαβ + CD8αα + IELs were nearly completely absent from C57BL/6 mice deficient in β 2 -microglobulin (B2m −/− mice; Fig. 6c ). We crossed B2m −/− mice with B7-deficient or Bcl-2-transgenic mice, each of which had a substantial frequency of developmentally diverted thymocytes ( Figs. 1 and 2) . TCRαβ + CD8αα IELs were present in the B7-deficient or Bcl-2-transgenic B2m −/− progeny of each cross (Fig. 6c) , which demonstrated that developmentally diverted T cells did in fact differentiate in vivo into TCRαβ + CD8αα + IELs. To confirm that finding, we sought to determine if TCRαβ + CD8αα + IELs displayed the same TCR V β repertoire as that displayed by developmentally diverted TCRαβ + DN thymocytes. Indeed, in B7-deficient BALB/c mice, TCRs expressing superantigen-reactive V β molecules were over-represented at essentially identical frequencies in both TCRαβ + CD8αα + IELs and TCRαβ + DN thymocytes (Fig. 7a) . We concluded that developmentally diverted TCRαβ + DN thymocytes differentiated in vivo into TCRαβ + CD8αα + IELs.
Developmental diversion and the origin of CD8aa + IELs
Having shown that developmentally diverted TCRαβ + DN thymocytes differentiated in vivo into TCRαβ + CD8αα + IELs, we wondered if all TCRαβ + CD8αα + IELs might be derived from cells that had undergone developmental diversion during negative selection in the thymus. If so, mice in which thymic clonal deletion was absent would have more TCRαβ + CD8αα + IELs than would wild-type mice. In fact, costimulationdeficient mice had many more TCRαβ + CD8αα + IELs than wild-type mice had (about ten times more; Fig. 7b) , which suggested that developmental diversion was the main origin of TCRαβ + CD8αα + IELs. We then wondered if the TCRαβ + CD8αα + IELs present in normal wild-type mice were also the progeny of thymocytes that had survived negative selection and had undergone developmental diversion. In fact, we found that even in wild-type mice, TCRαβ + CD8αα + IELs specifically overexpressed superantigen-reactive TCRs, but other T cell populations did not (Fig. 7c) . That finding suggested that in normal wild-type mice, substantial numbers of autoreactive T cells avoided clonal deletion and underwent developmental diversion, a conclusion that was also consistent with our observation that the frequency of superantigen-reactive TCRs in wild-type mice was always greater in TCRαβ + DN thymocytes than in SP4 or SP8 thymocytes (Figs. 3a and 5a and Supplementary Fig. 1a) .
The over-representation of autoreactive TCR specificities in CD8αα + IELs in normal and experimental mice, none of which were autoimmune, made us question the TCR responsiveness of CD8αα + IELs.
In fact, CD8αα + IELs resembled TCRαβ + DN thymocytes in being unresponsive to stimulation with anti-TCR and antigen-presenting cells in vitro without exogenous cytokines (Fig. 7d) . We concluded that TCRαβ + CD8αα + IELs were the progeny of cells that survived negative selection and underwent developmental diversion in the thymus.
Role of the transcription factor Runx3
Finally, we sought to gain molecular insight into the differentiation of developmentally diverted TCRαβ + DN thymocytes into CD8αα + IELs. Because such differentiation requires reactivation of Cd8a expression, which is a known function of the transcription factor Runx3 (ref. 30) , we considered that Runx3 might be required for this differentiation. To analyze this possibility, we used Bcl-2-transgenic mice also heterozygous for an endogenous Runx3 allele re-engineered to encode yellow fluorescent protein (YFP) instead of Runx3 (Runx3 +/YFP mice) 31 . Developmentally diverted TCRαβ + DN thymocytes in these Bcl-2-transgenic Runx3 +/YFP mice were YFP lo , whereas TCRαβ + CD8αα + IELs were YFP hi (Fig. 8a) , which indicated that Runx3 expression was upregulated at some point during the differentiation of TCRαβ + DN thymocytes into TCRαβ + CD8αα + IELs. To determine if that point was related to the reactivation of Cd8a, we stimulated TCRαβ + DN thymocytes in vitro with anti-TCR and IL-15 (Fig. 8b) . After that in vitro stimulation, TCRαβ + DN thymocytes expressed Runx3 and differentiated into CD8αα + cells (Fig. 8b) . To determine if their differentiation into CD8αα + cells required Runx3, we used Bcl-2-transgenic Runx3 YFP/YFP mice, which were Runx3 deficient because they had two Runx3 alleles re-engineered to encode YFP instead of Runx3 (Fig. 8b) . In vitro stimulation of TCRαβ + DN thymocytes that were Runx3 deficient did not induce their differentiation into CD8αα + cells, although it did induce YFP expression (Fig. 8b) . Thus, Runx3 was required for the reactivation of Cd8a expression by developmentally diverted TCRαβ + DN thymocytes and for their differentiation into CD8αα + cells in vitro. Applying those in vitro observations to the developmental fate of TCRαβ + DN thymocytes in vivo, we wondered if the differentiation of developmentally diverted TCRαβ + DN thymocytes into TCRαβ + CD8αα + IELs would be impaired in Runx3 YFP/YFP mice because they were Runx3 deficient. Indeed, Bcl-2-transgenic Runx3 YFP/YFP (Runx3-deficient) mice had significantly fewer TCRαβ + CD8αα + IELs than did Bcl-2-transgenic Runx3 +/YFP (Runx3-sufficient) mice, even though they had equal numbers of developmentally diverted TCRαβ + DN thymocytes (Fig. 8c) . We concluded that TCRs and IL-15 stimulated developmentally diverted TCRαβ + DN thymocytes to express Runx3, which promoted the reactivation of Cd8a and the differentiation of developmentally diverted TCRαβ + DN thymocytes into TCRαβ + CD8αα + IELs. Thus, we were able to integrate lineage choice during positive selection and lineage fate during negative selection into a unified picture of thymic development in which the developmental fate of TCR-signaled DP thymocytes is determined by TCR and costimulatory signals (Supplementary Fig. 7 ).
DISCUSSION
Here we have identified costimulatory signals from CD28 as being necessary for thymocytes to undergo clonal deletion during negative selection in vivo and have demonstrated that neither costimulation by CD28 nor clonal deletion was required for self-tolerance. Regardless of the presence or absence of CD28-mediated clonal deletion, strong TCR signaling prevented DP thymocytes bearing autoreactive TCRs from differentiating into conventional SP4 or SP8 T cells, so the absence of autoreactive TCRs on SP T cells was indicative of in vivo npg negative selection but was not necessarily indicative of in vivo clonal deletion. Indeed, DP thymocytes that had received strong signaling and bore autoreactive TCRs that survived negative selection did not differentiate into conventional SP T cells but instead underwent developmental diversion and differentiated into TCRαβ + DN thymocytes. Developmentally diverted TCRαβ + DN thymocytes, after leaving the thymus, migrated mainly to the intestine and received signaling via IL-15 to express Runx3 and to further differentiate into Runx3 + CD8αα + IELs. Clonal deletion and developmental diversion occurred during negative selection at the intermediate CD4 hi CD8 lo thymocyte stage of differentiation, the same point in thymocyte development at which lineage choice occurs during positive selection 1 . Thus, our study has distinguished in vivo negative selection from in vivo clonal deletion, has identified costimulation by CD28 as the in vivo signal required for clonal deletion during negative selection, and has identified TCRαβ + CD8αα + IELs as the ultimate fate of autoreactive cells that survive negative selection in the thymus.
During thymic selection, DP thymocytes that have received weak TCR signaling undergo positive selection into SP4 or SP8 T cells, whereas most DP thymocytes that have received strong TCR signaling undergo negative selection, which prevents them from differentiating into SP4 or SP8 T cells. Notably, as we have shown here, the absence of autoreactive TCR specificities among in vivo SP T cells was indicative of negative selection but was not necessarily indicative of clonal deletion. Consequently, our study has provided a new conceptual model of thymic selection in which 'positive selection' is the differentiation of signaled DP thymocytes into SP T cells and 'negative selection' is the prevention of their differentiation into SP T cells; 'developmental diversion' refers to their differentiation into mature T cells that are neither SP4 nor SP8 but are DN; and 'clonal deletion' refers to their death before maturation.
We used specific V β + TCRs to monitor the developmental fate of DP thymocytes that had received strong signaling by endogenously encoded proviral antigens of the Mtv family. DP thymocytes are the first cells in the thymus to express endogenously encoded TCRαβ complexes and are the cells that are subjected to thymic selection. As observed before 23 , DP thymocytes bearing superantigenreactive TCRs underwent negative selection, as they did not differentiate into SP4 or SP8 T cells. However, our study has documented that clonal deletion of superantigen-reactive thymocytes during negative selection additionally required costimulation by CD28. In the absence of CD28 costimulation, superantigen-reactive thymocytes survived negative selection and underwent developmental diversion to TCRαβ + DN thymocytes. Similarly, superantigen-reactive thymocytes that were prevented from undergoing clonal deletion by the expression of a transgene encoding Bcl-2 or Mcl-1 also survived negative selection and underwent developmental diversion into TCRαβ + DN thymocytes. Thus, costimulation by CD28 during negative selection was required for in vivo clonal deletion, which was prevented by transgenic expression of either Bcl-2 or Mcl-1.
The developmental diversion of surviving autoreactive thymocytes to TCRαβ + DN thymocytes precluded autoreactivity by removing the contribution of the coreceptors CD4 and CD8 to TCR signaling, which lessened their in vivo autoreactive potential, as did their expression of negative costimulatory receptors such as PD-1 (ref. 28 ). In addition, after leaving the thymus, developmentally diverted TCRαβ + DN thymocytes migrated to the intestine, where they were sequestered away from the rest of the body and were stimulated by IL-15 to express Runx3, which reactivated Cd8a expression and promoted their further differentiation into CD8αα + IELs that were hyporesponsive to TCR stimulation. Their CD8αα phenotype may have further diminished their autoreactive potential, as CD8αα surface complexes have been suggested to sequester the signaling kinase Lck away from the TCR 32 . Indeed, costimulation-deficient mice were free of autoimmunity despite our finding that they had many CD8αα + IELs bearing autoreactive TCR specificities and despite their lack of functionally suppressive Foxp3 + regulatory T cells 33 .
Developmental diversion occurs in TCR-signaled CD4 hi CD8 lo intermediate thymocytes that transcribe Cd4 but lack transcription of Cd8, with the result that differentiation into TCRαβ + DN thymocytes during negative selection requires only the termination of Cd4 expression. In fact, in intermediate thymocytes that transcribe Cd4 but lack transcription of Cd8, such termination occurs during MHC class I-specific positive selection into SP8 T cells, but in that case it is mediated by the transcription factor Runx3 (refs. 30, 34) , which additionally induces reactivation of Cd8 to result in 'coreceptor reversal' 35 . In contrast, developmental diversion into TCRαβ + DN thymocytes did not involve or require Runx3, which suggested that strong TCR stimulation of intermediate thymocytes during negative selection terminates Cd4 transcription independently of Runx3 and without reactivation of Cd8. Notably, Runx3-independent termination of Cd4 transcription by strong TCR signaling in intermediate thymocytes that transcribe Cd4 but lack transcription of Cd8 would also explain why negatively selected thymocytes become DN cells instead of SP4 T cells.
By identifying developmental diversion and clonal deletion as alternative outcomes of negative selection, our study has resolved many longstanding experimental contradictions. Published in vitro experiments have demonstrated that thymocyte death as a result of TCR signaling requires CD28 costimulation [10] [11] [12] [13] [14] and can be prevented by transgenic Bcl-2 expression 12,14 , whereas published in vivo experiments have arrived at opposite conclusions [18] [19] [20] [21] [22] . Our study here has shown that those contradictory observations were due mainly to the presumption that autoreactive thymocytes had been clonally deleted in vivo if they failed to differentiate into either SP4 or SP8 T cells. In fact, here we have documented that the absence of autoreactive TCR specificities on SP T cells in vivo indicated that autoreactive thymocytes had undergone negative selection but did not indicate that they had undergone clonal deletion. Our study has also resolved the discrepant observations that genetic deletion of the proapoptotic protein Bim interferes with clonal deletion 36 , whereas transgenic overexpression of the antiapoptotic protein Bcl-2 does not 20 . In fact, many features of Bim-deficient mice [37] [38] [39] resemble those of the Bcl-2-transgenic and Mcl-1-transgenic mice we studied here; thus, the results of our study would explain the high frequency of TCRαβ + DN thymocytes in mice deficient in Bim or the proapoptotic protein Puma 37,40,41 as resulting from their being autoreactive thymocytes that survived negative selection and underwent developmental diversion. Our study has also explained why SP4 and SP8 T cells bearing Mtv-6 reactive V β 3 + TCRs have been noted before in B7-deficient BALB/c mice but not Cd28 −/− BALB/c mice 24 . The discrepancy between these mice does not indicate an as-yet-unknown B7-specific receptor that signals clonal deletion in Cd28 −/− BALB/c mice 24 but is instead due to the fact that Mtv-6 is not encoded by the genome of B7-deficient BALB/c mice.
Although it has resolved many longstanding experimental contradictions, our study does contradict the experimental finding obtained with perinatal mice showing that blockade of costimulation by in vivo injection of anti-B7 rescues superantigen-reactive TCRs that are then expressed on SP4 T cells 42 . In our study here, genetic deletion of B7 ligands in B7-deficient mice also rescued superantigen-reactive TCRs; however, the rescued TCRs were not expressed on SP4 T cells but instead were expressed only on developmentally diverted TCRαβ + npg DN thymocytes and CD8αα + IELs. We think the explanation for this disparity is that injection of anti-B7 depletes the thymus of superantigenbearing B7 + cells and thus eliminates intrathymic expression of the negative selecting (superantigen) ligand.
Does developmental diversion occur in normal wild-type (costimulation-sufficient) mice? Costimulation-sufficient TCRtransgenic mice have a substantial number of TCRαβ + DN thymocytes 37, 41, 43 that can become CD8αα + IELs 29, 32, [43] [44] [45] [46] . However, transgenically expressed TCRs differ from endogenous TCRs in that they are expressed by early DN thymocytes before the DP stage of differentiation, so it is difficult to know if TCRαβ + DN thymocytes in TCR-transgenic mice are post-selection cells that result from developmental diversion or are preselection DN thymocytes that were developmentally arrested because their transgenically expressed TCR engaged high-affinity ligands in the thymic cortex 47, 48 . Notably, we found that in normal, nontransgenic mice, many or all TCRαβ + CD8αα + IELs were the progeny of thymocytes that survived negative selection and underwent developmental diversion in the thymus. Indeed, normal wild-type mice had a substantial number of TCRαβ + CD8αα + IELs (~5 × 10 6 ) in which TCRs with autoreactive specificities were overexpressed, which indicated that a substantial number of autoreactive T cells avoided clonal deletion and underwent developmental diversion in normal mice.
In conclusion, by distinguishing in vivo negative selection from in vivo clonal deletion, we have identified costimulation by CD28 as being critical for clonal deletion and have identified developmental diversion as an alternative outcome of negative selection. Moreover, we have identified TCRαβ + CD8αα + IELs as the ultimate fate of autoreactive T cells that survived negative selection and underwent developmental diversion in the thymus. Also, by showing that the fate of thymocytes undergoing negative selection was determined at the same point in differentiation as that of thymocytes undergoing positive selection, our study has integrated negative selection and positive selection into a unified picture of thymic selection.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
